|
Volumn 337, Issue 23, 1997, Pages 1690-1692
|
Choosing therapy for childhood asthma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
FLUTICASONE;
NEDOCROMIL SODIUM;
PLACEBO;
SALMETEROL XINAFOATE;
ASTHMA;
BRONCHODILATATION;
BRONCHUS HYPERREACTIVITY;
CHILD;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOUBLE BLIND PROCEDURE;
EDITORIAL;
FEMALE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
TREATMENT PLANNING;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-AGONISTS;
ASTHMA;
BECLOMETHASONE;
CHILD;
GLUCOCORTICOIDS;
HUMANS;
|
EID: 0030664979
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199712043372312 Document Type: Editorial |
Times cited : (19)
|
References (16)
|